Person

Jennifer L. Davis

Director, AbbVie

Current S&P 500 boards
1
Current roles
2
Open-market buys
$0
Open-market sales
$13.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Oct 2, 2025PGSale3,227$152.23$491K
Aug 19, 2025PGSale8,596$157.27$1.4M
Apr 29, 2025PGSale1,000$161.38$161K
Oct 2, 2024PGSale4,447$171.65$763K
Aug 20, 2024PGSale6,223$169.22$1.1M
Aug 17, 2023PGSale5,761$152.85$881K
Apr 24, 2023PGSale23,943$155.27$3.7M
Aug 23, 2022PGSale27,809$147.95$4.1M
Aug 17, 2022PGSale7,621$149.33$1.1M

SEC reporting-owner ID (CIK) 1916665 · all filings on EDGAR